Another study pointed out that inhibition or downregulation of CatG in non-obese diabetic mice reduced the activation of CD4+ T cells, improved the function of insulin-secreting β cells in the pancreas, and slowed down the progress of diabetes (Zou et al., 2017). This evidence concerns the gene CD4 and diabetes mellitus.